PyRIDostigmine bromide 105 mg 24HR Extended Release Oral Tablet
RxNorm 2695047
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2695047 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: pyRIDostigmine bromide 105 mg 24HR Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
24 HR pyridostigmine bromide 105 mg Extended Release Oral Tablet
(Atom ID: 12920049)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
24 HR pyRIDostigmine bromide 105 mg Extended Release Oral Tablet
(Atom ID: 12920060)
SYPrescribable
Synonym (SY):
Pyridostigmine bromide 105 mg (equivalent to pyridostigmine 72.87 mg) 24 HR Extended Release Oral Tablet
(Atom ID: 12920051)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
PyRIDostigmine bromide 105 mg (equivalent to pyRIDostigmine 72.87 mg) 24 HR Extended Release Oral Tablet
(Atom ID: 12920062)
SYPrescribable
Synonym (SY):
Pyridostigmine bromide 105 mg 24 HR Extended Release Oral Tablet
(Atom ID: 12920052)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
PyRIDostigmine bromide 105 mg 24 HR Extended Release Oral Tablet
(Atom ID: 12920059)
PSNPrescribable